β-Adrenoreceptor agonists in the management of pain associated with renal colic: a systematic review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 27324714.
- Also identified by DOI 10.1136/bmjopen-2016-011315 and PMC identifier 4916590.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether β-adrenoreceptor agonists are effective analgesics for patients with renal colic through a systematic review of the literature. Adult emergency departments or acute assessment units. Human participants with proven or suspected renal colic. β-adrenoreceptor agonists. Primary: level of pain at 30 min following administration of the β-agonist. Secondary: level of pain at various time points following β-agonist administration; length of hospital stay; analgesic requirement; stone presence, size and position; degree of hydronephrosis. 256 records were screened and 4 identified for full-text review. No articles met the inclusion criteria. There is no evidence to support or refute the proposed use of β-agonists for analgesia in patients with renal colic. Given the biological plausibility and existing literature base, clinical trials investigating the use of β-adrenoreceptor agonists in the acute setting for treatment of the pain associated with renal colic are recommended. CRD42015016266.
Medical subject headings
- Adrenergic beta-Agonists
- Analgesics
- Renal Colic